Home » Topics » BioWorld Science

BioWorld Science
RSS

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

HIV fusin described in Science by NIAID researchers

May 17, 1996

UNAIDS initiates clinical program to evaluate Advantage 24 in STD transmission

May 17, 1996

Lexirin cleared to enter phase I

May 17, 1996

FDA okays second Cell Genesys AIDS gene therapy trial

May 17, 1996

Toho University reports anti-HIV zinc complex dimers

May 17, 1996

HNK20 moves to phase III

May 17, 1996

HMR reports anti-HIV guanine derivative

May 17, 1996

CMV NeutraGAM development update

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...